Executive Summary
Where are the pharma and biotech sectors heading in 2004 and beyond...? The management report ’Future Growth Strategies: Drivers of sustainable development within the biotech, specialty and major pharma sectors’, provides the timely analysis senior executives need to maximize business opportunities in 2004. This report assesses favored growth strategies for pharma and biotechs and offers productive solutions to assure long-term success. This report examines the feasibility of blockbuster drug development as a foundation of major pharma growth and proposes alternatives to expansion through M&A, expounding the benefits of in-licensing and then networked growth. It also focuses on the group of small ethical, generics, drug delivery and certain biotech firms that together constitute the specialty pharma sector. Fundamentally this report will provide you with the analysis you need to; grow in your own sector successfully, understand other sectors’ growth strategies, take advantage of new market opportunities and prepare counter strategies for threats presented by new entrants.
Other selected research from the 'Business Development' category:
Competitive Outlook on HCV: What to Know and Expect in R&D and Business Development
Partnering Agreements with AstraZeneca 2010
This report provides all the information you require to better understand AstraZeneca Labs and its partnering interests and activities over the past five years. Learn More